211 related articles for article (PubMed ID: 28168426)
1. Mitochondrial Metabolism Regulates Microtubule Acetylome and Autophagy Trough Sirtuin-2: Impact for Parkinson's Disease.
Esteves AR; Arduíno DM; Silva DF; Viana SD; Pereira FC; Cardoso SM
Mol Neurobiol; 2018 Feb; 55(2):1440-1462. PubMed ID: 28168426
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Metabolism Power SIRT2-Dependent Deficient Traffic Causing Alzheimer's-Disease Related Pathology.
Silva DF; Esteves AR; Oliveira CR; Cardoso SM
Mol Neurobiol; 2017 Aug; 54(6):4021-4040. PubMed ID: 27311773
[TBL] [Abstract][Full Text] [Related]
3. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology.
Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM
Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013
[TBL] [Abstract][Full Text] [Related]
4. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease.
Esteves AR; Gozes I; Cardoso SM
Biochim Biophys Acta; 2014 Jan; 1842(1):7-21. PubMed ID: 24120997
[TBL] [Abstract][Full Text] [Related]
5. Loss of NAD-Dependent Protein Deacetylase Sirtuin-2 Alters Mitochondrial Protein Acetylation and Dysregulates Mitophagy.
Liu G; Park SH; Imbesi M; Nathan WJ; Zou X; Zhu Y; Jiang H; Parisiadou L; Gius D
Antioxid Redox Signal; 2017 May; 26(15):849-863. PubMed ID: 27460777
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic.
Arduíno DM; Esteves AR; Cortes L; Silva DF; Patel B; Grazina M; Swerdlow RH; Oliveira CR; Cardoso SM
Hum Mol Genet; 2012 Nov; 21(21):4680-702. PubMed ID: 22843496
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial metabolic control of microtubule dynamics impairs the autophagic pathway in Parkinson's disease.
Cardoso SM; Esteves AR; Arduíno DM
Neurodegener Dis; 2012; 10(1-4):38-40. PubMed ID: 22156537
[TBL] [Abstract][Full Text] [Related]
8. Decreased SIRT2 activity leads to altered microtubule dynamics in oxidatively-stressed neuronal cells: implications for Parkinson's disease.
Patel VP; Chu CT
Exp Neurol; 2014 Jul; 257():170-81. PubMed ID: 24792244
[TBL] [Abstract][Full Text] [Related]
9. A redox-mediated conformational change in NQO1 controls binding to microtubules and α-tubulin acetylation.
Siegel D; Bersie S; Harris P; Di Francesco A; Armstrong M; Reisdorph N; Bernier M; de Cabo R; Fritz K; Ross D
Redox Biol; 2021 Feb; 39():101840. PubMed ID: 33360352
[TBL] [Abstract][Full Text] [Related]
10. The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.
Esteves AR; G-Fernandes M; Santos D; Januário C; Cardoso SM
Mol Neurobiol; 2015 Dec; 52(3):1804-1820. PubMed ID: 25394383
[TBL] [Abstract][Full Text] [Related]
11. Modulation Of Microtubule Acetylation By The Interplay Of TPPP/p25, SIRT2 And New Anticancer Agents With Anti-SIRT2 Potency.
Szabó A; Oláh J; Szunyogh S; Lehotzky A; Szénási T; Csaplár M; Schiedel M; Lőw P; Jung M; Ovádi J
Sci Rep; 2017 Dec; 7(1):17070. PubMed ID: 29213065
[TBL] [Abstract][Full Text] [Related]
12. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.
Ghosh A; Tyson T; George S; Hildebrandt EN; Steiner JA; Madaj Z; Schulz E; Machiela E; McDonald WG; Escobar Galvis ML; Kordower JH; Van Raamsdonk JM; Colca JR; Brundin P
Sci Transl Med; 2016 Dec; 8(368):368ra174. PubMed ID: 27928028
[TBL] [Abstract][Full Text] [Related]
14. Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.
Harrison IF; Smith AD; Dexter DT
Neurosci Lett; 2018 Feb; 666():48-57. PubMed ID: 29273397
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.
de Oliveira RM; Vicente Miranda H; Francelle L; Pinho R; Szegö ÉM; Martinho R; Munari F; Lázaro DF; Moniot S; Guerreiro P; Fonseca-Ornelas L; Marijanovic Z; Antas P; Gerhardt E; Enguita FJ; Fauvet B; Penque D; Pais TF; Tong Q; Becker S; Kügler S; Lashuel HA; Steegborn C; Zweckstetter M; Outeiro TF
PLoS Biol; 2017 Mar; 15(3):e2000374. PubMed ID: 28257421
[TBL] [Abstract][Full Text] [Related]
16. Regulation of SIRT2-dependent α-tubulin deacetylation by cellular NAD levels.
Skoge RH; Dölle C; Ziegler M
DNA Repair (Amst); 2014 Nov; 23():33-8. PubMed ID: 24814981
[TBL] [Abstract][Full Text] [Related]
17. p27 controls autophagic vesicle trafficking in glucose-deprived cells via the regulation of ATAT1-mediated microtubule acetylation.
Nowosad A; Creff J; Jeannot P; Culerrier R; Codogno P; Manenti S; Nguyen L; Besson A
Cell Death Dis; 2021 May; 12(5):481. PubMed ID: 33986251
[TBL] [Abstract][Full Text] [Related]
18. Microtubule acetylation dyshomeostasis in Parkinson's disease.
Naren P; Samim KS; Tryphena KP; Vora LK; Srivastava S; Singh SB; Khatri DK
Transl Neurodegener; 2023 May; 12(1):20. PubMed ID: 37150812
[TBL] [Abstract][Full Text] [Related]
19. The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS.
Maxwell MM; Tomkinson EM; Nobles J; Wizeman JW; Amore AM; Quinti L; Chopra V; Hersch SM; Kazantsev AG
Hum Mol Genet; 2011 Oct; 20(20):3986-96. PubMed ID: 21791548
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial metabolism modulation: a new therapeutic approach for Parkinson's disease.
Arduíno DM; Esteves AR; Oliveira CR; Cardoso SM
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):105-19. PubMed ID: 20201821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
